A 66-year-old Aboriginal woman from a remote community has established rheumatic heart disease following multiple episodes of acute rheumatic fever in childhood. She has mild residual mitral regurgitation and no penicillin allergy. According to current Australian RHD guidelines, what is the standard regimen for secondary prophylaxis to prevent recurrent acute rheumatic fever?